This presentation provides strategies with the prebiotic 2’fucosyllactose, a human milk oligosaccharide, targeted to promote a healthy microbiome in patients with dysbiosis. Dysbiosis is associated with many gastrointestinal as well as extra-intestinal conditions and refers to an altered or imbalanced gut flora. Dysbiosis may be due to several factors including:

  • A suboptimal diet – which could include excessive refined carbohydrates and sugars, and inadequate dietary fiber
  • Antibiotic exposures – An example we’re probably all familiar with is antibiotic-associated diarrhea (AAD). One of the most severe examples is a C diff infection following antibiotic use
  • Excessive alcohol and stress can lead to dysbiosis

When the gut is in a state of dysbiosis, the patient’s intestinal epithelium may become damaged and toxic metabolites and excessive gas may be produced. Immune function may be altered, including an excessive inflammatory response leading to rapid turnover of the intestinal epithelial cells

Download and view the slides

Share this:

Resources from our research partners and collaborations

Sign up for the MHICN Newsletter

Your Weekly Nutrition Bulletin features the latest content on topics spanning our therapeutic platforms from MHICN research staff and clinical partners. Receive videos, clinical modules, research reviews and more by email each week. Sign up here or view previous weeks' newsletters.

Subscribe View Newsletter Archives

Continuing Education

MHICN has partnered with leaders in preventive medicine, integrative medicine, and medical education to provide cutting-edge education for providers of all backgrounds with an interest in functional and lifestyle medicine. We are excited to share these free educational modules featuring podcasts, videos, and print articles.

Learn More